Expression Analysis Announces a GWAS Data Analysis and Resequencing Grant
News Oct 02, 2008
Part of the grant will include GWAS data analysis through a proprietary tool that simultaneously analyzes allelic and copy number variations, accomplishing in days what typically takes months. The resequencing will be performed using Helicos True Single Molecule Sequencing (tSMS)™ technology.
The grant seeks projects that show promise of identifying genetic element(s) that are important to human health and disease. There must be a strong case that the trait has a genetic basis and important health consequences.
“With the recent advancements in detecting genetic variation and new next-generation sequencing technology, it is important to further research in efforts to identify additional genetic elements important to human health and disease,” stated Steve McPhail, CEO of Expression Analysis. “The goal of this grant is to apply these technologies to assist researchers in identifying discreet genetic mechanisms of disease,” concluded McPhail.
Interested parties are encouraged to apply through the company’s web site: www.ExpressionAnalysis.com/Grant. Applications are being accepted through December 15, 2008.
2nd International Conference on Pharmaceutical Research & Innovations in Pharma Industry
May 30 - May 31, 2019